Lv1
40 积分 2022-07-19 加入
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
1天前
已完结
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial
1个月前
已完结
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
1个月前
已完结
Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
1个月前
已完结
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
2个月前
已完结
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
2个月前
已完结
Target Product Profile and Clinical Development Plan
3个月前
已完结
Clinical and translational advances in ovarian cancer therapy
3个月前
已完结
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial
4个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
5个月前
已完结
皖公网安备34019202002308
